Login | Register

COPD Drug Tudorza Pressair Wins FDA Approval

Tudorza Pressair, a drug for the treatment of chronic obstructive pulmonary disease (COPD), has received approval from the US Food and Drug Administration (FDA)...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *